This inventor holds 4 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: The University of Texas System. Active years: 2011-2021.
Location History:
- League City, TX (US) (2011 - 2017)
- Houston, TX (US) (2017)
- Galveston, TX (US) (2021)
Company Filing History:
Years Active: 2011-2021
Title: Innovations of Xiaodong Cheng
Introduction
Xiaodong Cheng is a notable inventor based in League City, TX (US). He has made significant contributions to the field of medical research, particularly in the development of novel therapeutic agents. With a total of 4 patents to his name, Cheng's work focuses on innovative solutions for chronic pain management.
Latest Patents
Cheng's latest patents include groundbreaking work on EPAC antagonists. These embodiments are directed to a series of novel EPAC antagonists that are designed, synthesized, and evaluated to develop diversified analogues based on the scaffold of the previously identified high-throughput (HTS) hit ESI-09. Additionally, he has developed methods and compositions for treating chronic pain. Certain embodiments are directed to methods of treating pain, including chronic or neuropathic pain, by administering an effective amount of an EPAC inhibitor.
Career Highlights
Xiaodong Cheng is affiliated with the University of Texas System, where he continues to advance his research and innovation. His work has garnered attention for its potential impact on pain management therapies.
Collaborations
Cheng collaborates with talented individuals in his field, including Fang Mei and Jia Zhou. Their combined expertise contributes to the success of their research initiatives.
Conclusion
Xiaodong Cheng's innovative work in developing EPAC antagonists and methods for treating chronic pain highlights his significant contributions to medical research. His ongoing efforts at the University of Texas System promise to lead to advancements in therapeutic solutions for patients suffering from pain.